TC BioPharm continues to Rally on Strategic Collaboration News

(24/7 MARKET NEWS) – TC Biopharm (NASDAQ: TCBP) opened yesterday’s regular session at $5.25, within a penny of its session high, but dropped to as low as $3.94, before rallying to close at $4.93, 45-cents higher (+10.04%), on volume of 3,601,013 shares, after yesterday morning’s announcement of a strategic collaboration with The University of Texas MD Anderson Cancer Center to expand the knowledge base of how gamma-delta T cells work in oncology settings.

TC Biopharm’s rally is continuing in this morning’s premarket, as it hit a high of $6.55 and currently trading at $5.69, up $0.76 (+15.42%), on 2.2 million shares.

Its 52-week range is $2.81 to $175.00. It’s traded above the $9 level twice this month, but closed those sessions only slightly in the green, so, if it does run, it may be best to scalp. Also, keep an eye on a potential pullback, just before the regular session open.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist